Song Tianqiang
Department of Hepatobiliary Tumors, Tianjin Medical University Cancer Institute and Hospital.
Drug Discov Ther. 2015 Oct;9(5):319-30. doi: 10.5582/ddt.2015.01051.
Hepatocellular carcinoma (HCC) is a common and lethal malignancy worldwide that arises within the context of a host of diseases. Surgery is the primary option for tumor treatment and is thus the most effective therapy to allow the best overall survival and recurrence-free survival for patients. One aim of this paper is to present and discuss recent advances in the surgical treatment of HCC such as associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), laparoscopic hepatectomy, and robotic liver resection, and another aim of this paper is to highlight current issues in the surgical treatment of HCC such as extended indications.
肝细胞癌(HCC)是一种在全球范围内常见且致命的恶性肿瘤,它在多种疾病背景下发生。手术是肿瘤治疗的主要选择,因此是使患者获得最佳总生存期和无复发生存期的最有效治疗方法。本文的一个目的是介绍和讨论肝细胞癌手术治疗的最新进展,如联合肝脏分隔和门静脉结扎分期肝切除术(ALPPS)、腹腔镜肝切除术和机器人肝脏切除术,本文的另一个目的是强调肝细胞癌手术治疗中的当前问题,如扩大适应证。